We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Sleeve Gastrectomy Improves LV Systolic Function

By HospiMedica International staff writers
Posted on 18 May 2016
Sleeve gastrectomy improves left ventricular (LV) systolic function in both men and women, according to a new study.

Researchers at Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital (Istanbul, Turkey) conducted a study in 53 obese patients referred for sleeve gastrectomy to evaluate and compare the effects of weight lost after the procedure on left ventricular (LV) systolic function, using both two-dimensional speckle tracking (2D-STE) and three-dimensional echocardiography (3DE) prior to and six months after surgery.

The results showed that all patients demonstrated a significant decrease in body mass index (BMI), body weight, blood pressure, heart rate, LV end-diastolic dimension, myocardial wall thickness, LV mass, LV mass index, LV mass/height2.7, LV end-diastolic and -systolic volume, and stroke volume (SV) at six months after surgery. More...
There was no significant difference in measured variables between men and women, except for baseline LV end-diastolic dimension, and baseline and after surgery LV mass, LV mass index, and LV mass/height2.7, which were all significantly higher in men. The study was published early online on April 27, 2016, in the Journal of Clinical Ultrasound.

“Sleeve gastrectomy improves LV systolic function and contributes to reverse LV remodeling in both genders,” concluded lead author Tuğba Kemaloğlu Öz, MD, and colleagues.

Sleeve gastrectomy is a restrictive form of weight loss surgery intended for the morbidly obese, which permanently reduces the size of the stomach by removing the lateral 2/3 of the stomach with a stapling device. While the stomach is drastically reduced in size, function is preserved, with no malabsorption of nutrients and supplements. The procedure avoids the problems associated with bypass forms of weight loss surgery including anemia, intestinal obstruction or blockage, osteoporosis, and protein and vitamin deficiency, and since about 100-200 ml of stomach capacity is maintained, there are very few restrictions on food consumption.

Dividing LV mass by height to the allometric power of 2.7 is the most promising normalization method in terms of practicality and usefulness from a clinical and scientific standpoint for scaling myocardial mass to body size.

Related Links:
Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Immobilization System
Cranial 4Pi Immobilization
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: 123RF

AI Platform Screens for Amyloid Cardiomyopathy Using ECG Images

Amyloid cardiomyopathy is a heart disease caused by deposits of misfolded proteins in the cardiac muscle. It is often missed until patients develop serious complications such as heart failure.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.